Banner Image

Test Directory

Y Chromosome Microdeletion, DNA Analysis

Test Summary

To detect Y chromosome microdeletions associated with oligospermia and azoospermia. About 15-20% of azoospermic men and about 10% of severely oligospermic men present with microdeletions of Yq. This test targets 20 genetic loci, including those recommended by the European Quality Monitoring Network Group (Int J Andr 22:292-299 (1999).

Aliases

  • N/A

Specimen Collection

Special Instructions

N/A

Preferred Specimen

4 mL whole blood collected in an EDTA (lavender-top) tube

Minimum Volume

3 mL

Instructions

Specimen type: Whole blood, lavender-top preferred. Specimen stability is crucial. Store and ship ambient immediately. Do not freeze.

Extracted DNA: Please call 1-866-GENE-INFO for additional information.

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: 8 days
  • Refrigerated: 8 days
  • Frozen: Unacceptable

Limitations

This assay is limited to the detection of deletions that affect the markers listed above. We are unable to determine if the absence of a single marker is caused by a deletion or a nucleotide sequence variation in the binding site for one of the PCR primers used to amplify that marker. Although rare, false positive or false negative results may occur. All results should be interpreted in the context of clinical findings, relevant history, and other laboratory data.

Other Acceptable Specimens

Whole blood collected in: ACD (yellow-top)

Unacceptable Specimens

N/A

Order Code

YCHROM

EPIC (Premier) Code

LAB3190

Includes

N/A

CPT Code

  • 81403

Billing Code

  • 670862

CPT Statement

Methodology

Agarose Gel Electrophoresis • Polymerase Chain Reaction (PCR)

FDA Status

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Physician Attestation of Informed Consent

N/A

Testing Laboratory

Quest Diagnostics Nichols Institute
33608 Ortega Highway
San Juan Capistrano CA, 92675

Department

Reference Testing

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Monday, Wednesday, Friday; Report available: 4 - 5 days

Specimen Collection

Special Instructions

N/A

Preferred Specimen

4 mL whole blood collected in an EDTA (lavender-top) tube

Minimum Volume

3 mL

Instructions

Specimen type: Whole blood, lavender-top preferred. Specimen stability is crucial. Store and ship ambient immediately. Do not freeze.

Extracted DNA: Please call 1-866-GENE-INFO for additional information.

Patient Preparation

N/A

Storage

N/A

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: 8 days
  • Refrigerated: 8 days
  • Frozen: Unacceptable

Limitations

This assay is limited to the detection of deletions that affect the markers listed above. We are unable to determine if the absence of a single marker is caused by a deletion or a nucleotide sequence variation in the binding site for one of the PCR primers used to amplify that marker. Although rare, false positive or false negative results may occur. All results should be interpreted in the context of clinical findings, relevant history, and other laboratory data.

Other Acceptable Specimens

Whole blood collected in: ACD (yellow-top)

Unacceptable Specimens

N/A

Billing

CPT Code

  • 81403

Billing Code

  • 670862

CPT Statement

Result Information

Methodology

Agarose Gel Electrophoresis • Polymerase Chain Reaction (PCR)

Testing Laboratory

N/A

Reference Range

See Laboratory Report

Setup Schedule / Expected Turnaround Time

Monday, Wednesday, Friday; Report available: 4 - 5 days